| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MMM | Common Stock | Options Exercise | $379,893 | +2,845 | +1745% | $133.53 | 3,008 | 29 Nov 2024 | Direct | |
| transaction | MMM | Common Stock | Tax liability | $146,215 | -1,095 | -36% | $133.53 | 1,913 | 29 Nov 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MMM | Restricted Stock Units | Options Exercise | $0 | -2,845 | -33% | $0.000000 | 5,691 | 29 Nov 2024 | Common Stock | 2,845 | Direct | F2, F3, F4 |
| Id | Content |
|---|---|
| F1 | Includes shares acquired under 3M's General Employee Stock Purchase Plan. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of 3M common stock. |
| F3 | The restricted stock units vest in three equal annual installments beginning December 1, 2024. |
| F4 | The shares originally reported were adjusted due to the spin-off of Solventum, the Company's healthcare business group, on April 1, 2024. |